General antioxidant activity of blood of patients with limited sclerodermia and its correction
Year: 2017, volume 13 Issue: №3 Pages: 640-643
Heading: Dermatovenerology Article type: Original article
Authors: Tlish M.M., Sorokina N.V.
Organization: Kuban State Medical University
Heading: Dermatovenerology Article type: Original article
Authors: Tlish M.M., Sorokina N.V.
Organization: Kuban State Medical University
Summary:
Objective: to increase efficiency and to reduce the time of treatment of patients with circumscribed sclerodermia. Material and Methods. 60 patients with circumscribed sclerodermia were under supervision. Two groups of these patients were formed with method of adaptive randomization. In the comparison group the patients received standard therapy according to the federal clinical guidelines. In the general group the standard complex treatment with additional antioxidant therapy was underwent. The course of treatment in all patients was 21 days. The results of treatment were evaluated in accordance with the dynamics of cutaneous pathological process and the concentration of common an-tioxidants. Results. Based on the obtained results of the assessment of the dynamics of the cutaneous pathological process, it is obvious that the regress of dermatosis was more rapid and more active in the general group and was accompanied by a more pronounced increase in the total antioxidant activity of the blood. Conclusion. The proposed method of treatment, having an antioxidant effect and high clinical efficacy, enhances the general antioxidant activity of the blood and allows reducing the duration of treatment of patients with circumscribed scleroderma and, as a consequence, the course of systemic and local corticosteroid therapy.
Bibliography:
1. Kubanova AA, Kubanov AA, Volnukhin VA. Federal'nye klinicheskie rekomendatsii. Dermatovenerologiya 2015: Bolezni kozhi. Infektsii, peredavaemye polovym putem. Moskow: Delo-voy ekspress, 2016; 760 p.
2. Dooley A, Bruckdorfer KR, Abraham DJ. Modulation of fi-brosis in systemic sclerosis by nitric oxide and antioxidants. Cardiology research and practice 2012; Article ID 521958: 9
3. Yagoda AV, Gladkikh NN. Autoimmune aspects of disorders of collagen homeostasis in undifferentiated connective tissue dysplasia. Medical Immunology 2007; 9 (1): 61-68
4. Yamamoto Т. Autoimmune mechanisms of scleroderma and a role of oxidative stress. Self/nonself 2011; 2 (1): 4-10
5. Gurskiy GE. Modern ideas about scleroderma. Klinich-eskaya dermatologiya i venerologiya 2012; 10 (2): 4-10
6. Guseva NG. Systemic sclerosis: clinical features, diagnosis, treatment. Russian Journal of Skin and Venereal Diseases 2002; 4: 5-15
7. Distler О, Cozzio A. Systemic sclerosis and localized scleroderma:current concepts and novel targets for therapy. Sem. in Immunopathol 2016; 38 (1): 87-95
8. Volnukhin VA, Katunina OR, Muradyan NL. Of disorders and t-cell immune processes in the skin of patients with limited scleroderma and their dynamics in the process of UVA1- therapy. Vestnik dermatologii i venerologii 2009; (6): 74-80
9. Mahoney JA, Rosen A. Apoptosis and autoimmunity. Curr Opin Immunol 2005; 17: 583-588
10. Sambo P, Baroni SS, Luchetti M, et al. Oxidative stress in scleroderma: Maintenance of scleroderma fibroblast pheno-type by the constitutive upregulation of reactive oxygen species generation through the NADPH oxidase complex pathway. Arthritis Rheum 2001; 44: 2653-2664.
| Attachment | Size |
|---|---|
| 2017_03-1_640-643.pdf | 244.99 KB |
Русский
English